|
SLNCF Silence Therapeutics plc 1479615 |
| Balance Sheet |
|
Current Assets
|
$102,852,000.00 |
|
Assets
|
$115,123,000.00 |
|
Current Liabilities
|
$10,460,000.00 |
|
Liabilities
|
$65,721,000.00 |
|
Equity
|
$49,402,000.00 |
|
Shares Out
|
141703840.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-15,603,000.00 |
|
Investing Cash Flow
|
$10,000,000.00 |
| Market Analysis |
Market Cap
|
$212,555,760.00 |
|
Price
|
$1.50 |
|
BVPS
|
0.35 |
|
PB
|
4.29 |
|
EPS
|
-0.11 |
|
PS
|
125.92 |
|
FCF
|
$-15,603,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:54 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:58 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLNCF documents filed with the SEC.
SLNCF Filings
Clear
